Page last updated: 2024-08-18

triphenyl phosphate and rosiglitazone

triphenyl phosphate has been researched along with rosiglitazone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Blum, BC; Emili, A; Farmer, S; Hekman, R; Kim, S; Rabhi, N; Schlezinger, JJ; Wynne, K1

Other Studies

1 other study(ies) available for triphenyl phosphate and rosiglitazone

ArticleYear
Triphenyl phosphate is a selective PPARĪ³ modulator that does not induce brite adipogenesis in vitro and in vivo.
    Archives of toxicology, 2020, Volume: 94, Issue:9

    Topics: 3T3-L1 Cells; Adipocytes; Adipocytes, Beige; Adipogenesis; Adipose Tissue; Animals; Cell Differentiation; Mice; Organophosphates; PPAR gamma; Rosiglitazone; Toxicity Tests

2020